The rise of Viagra initially fueled a boom for pharma, however recent changes present a complicated outlook for shareholders. Generic alternatives are eroding revenue, and continued litigation add more difficulty to https://jessetpoi551086.blog-kids.com/41601333/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet